In an age of increasingly bespoke healthcare, Elizabeth Philp has become a formidable voice of innovation, particularly in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a push to make bespoke medications more accessible, questioning the standard one-size-fits-all